Devleena Shivakumar – Innovate AI 2026
Session 1: AI in Health Care
Devleena Shivakumar, Ph.D.
Devleena Shivakumar is executive director and head of computational chemistry at Revolution Medicines, where she leads computational efforts to advance targeted oncology therapeutics with a particular focus on pancreatic and lung cancers. With over 20 years of experience in computational chemistry and drug discovery, Shivakumar brings deep expertise from her previous roles at leading pharmaceutical and technology companies including Merck, Gilead Sciences and Schrödinger.
Shivakumar earned her Ph.D. in computational chemistry from the University of California, Santa Barbara, followed by postdoctoral research at the Scripps Research Institute and the University of Chicago.
She is passionate about exploring and integrating artificial intelligence and machine learning approaches into traditional drug discovery workflows. Her extensive industry experience spans the full spectrum of drug discovery from early-stage target identification through clinical candidate selection, making her a recognized leader in the field.